Farmacología y Toxicología
Departamento
Instituto de Investigación Sanitaria Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (97)
2024
-
Infectious complications following major heart surgery from the day of the surgery to hospital discharge
BMC Infectious Diseases, Vol. 24, Núm. 1
-
N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia
Translational Psychiatry, Vol. 14, Núm. 1
-
THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation
Psychiatry Research, Vol. 331
-
Vitamin D and Pulmonary Arterial Hypertension
Archivos de Bronconeumologia
2023
-
Analysis of common genetic variation across targets of microRNAs dysregulated both in ASD and epilepsy reveals negative correlation
Frontiers in Genetics, Vol. 14
-
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)
Frontiers in Pharmacology
-
Dietary Supplementation with a Cocoa–Carob Blend Modulates Gut Microbiota and Prevents Intestinal Oxidative Stress and Barrier Dysfunction in Zucker Diabetic Rats
Antioxidants, Vol. 12, Núm. 8
-
Glycolysis in pulmonary arterial hypertension and metabolic reprogramming
Glycolysis: Tissue-Specific Metabolic Regulation in Physio-pathological Conditions (Elsevier), pp. 267-296
-
Hydrogen sulfide regulates the redox state of soluble guanylate cyclase in CSE-/- mice corpus cavernosum microcirculation
Pharmacological Research, Vol. 194
-
Immune System and Brain/Intestinal Barrier Functions in Psychiatric Diseases: Is Sphingosine-1-Phosphate at the Helm?
International Journal of Molecular Sciences, Vol. 24, Núm. 16
-
Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
Frontiers in Pharmacology, Vol. 14
-
Neuroimaging Revealed Long-Lasting Glucose Metabolism Changes to Morphine Withdrawal in Rats Pretreated with the Cannabinoid Agonist CP-55,940 during Periadolescence
European Neuropsychopharmacology, Vol. 69, pp. 60-76
-
Neutrophil β1 adrenoceptor blockade blunts stroke-associated neuroinflammation
British Journal of Pharmacology, Vol. 180, Núm. 4, pp. 459-478
-
Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension
American Journal of Respiratory Cell and Molecular Biology, Vol. 69, Núm. 2, pp. 147-158
-
Oxidized soluble guanylyl cyclase causes erectile dysfunction in alcoholic mice
British Journal of Pharmacology, Vol. 180, Núm. 18, pp. 2361-2376
-
Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart
Journal of Physiology, Vol. 601, Núm. 17, pp. 3717-3737
-
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities
PLoS pathogens, Vol. 19, Núm. 1, pp. e1011063
-
Recent natural selection conferred protection against schizophrenia by non-antagonistic pleiotropy
Scientific Reports, Vol. 13, Núm. 1
-
Sigma-1 receptor modulation fine-tunes KV1.5 channels and impacts pulmonary vascular function
Pharmacological Research, Vol. 189
-
The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit
Biomedicine and Pharmacotherapy, Vol. 164